Rentschler Biopharma SE

BRIEF

published on 10/06/2025 at 15:05, 3 months 23 days ago

Rentschler Biopharma Expands Services in Japan and South Korea

Rentschler Biopharma Strategic Expansion Biopharmaceutical Development Japan And South Korea BioProcess International Asia
PRESS RELEASE

published on 10/06/2025 at 15:00, 3 months 23 days ago

Rentschler Biopharma further expands its services in Japan and South Korea and will attend BioProcess International Asia
Rentschler Biopharma expands services in Japan and South Korea, showcasing innovative solutions at BioProcess International Asia conference. Strong strategic focus on client partnerships and market growth

Rentschler Biopharma Biopharmaceuticals Japan South Korea BioProcess International Asia
BRIEF

published on 05/20/2025 at 10:05, 8 months 10 days ago

Rentschler Biopharma Achieves ISO 50001 Certification

Sustainability Energy Management Rentschler Biopharma Biopharmaceuticals ISO 50001
PRESS RELEASE

published on 05/20/2025 at 10:00, 8 months 10 days ago

Rentschler Biopharma achieves ISO 50001 certification for energy management
Rentschler Biopharma achieves ISO 50001 certification for energy management, demonstrating commitment to sustainability and efficiency

Sustainability Efficiency Energy Management Rentschler Biopharma ISO 50001 Certification
BRIEF

published on 03/20/2025 at 15:05, 10 months 9 days ago

Rentschler Biopharma Names Robert Panting as VP Strategy

Rentschler Biopharma Biopharmaceuticals Global Strategy Robert Panting Client Program Management
PRESS RELEASE

published on 03/20/2025 at 15:00, 10 months 9 days ago

Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy. Dr. Panting to lead global Strategy initiatives and CPM functions in biopharmaceutical industry

Strategy Rentschler Biopharma Robert Panting VP Global Client Program Management
BRIEF

published on 02/20/2025 at 13:05, 11 months 10 days ago

Rentschler Biopharma Promotes Patrick Meyer to Global Head of Business Development

CDMO Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer
PRESS RELEASE

published on 02/20/2025 at 13:00, 11 months 10 days ago

Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development
Rentschler Biopharma appoints Patrick Meyer as Global Head of Business Development, emphasizing internal talent and client-focused strategy. Dr. Meyer will lead the global commercial strategy

Business Development Rentschler Biopharma Biopharmaceuticals Patrick Meyer Global Head
BRIEF

published on 01/30/2025 at 14:05, 11 months 30 days ago

Rentschler Biopharma Announces Strategic Realignment of Global Operations

Rentschler Biopharma Strategic Realignment Biologics Focus Stevenage Closure Investment In Growth
PRESS RELEASE

published on 01/30/2025 at 14:00, 11 months 30 days ago

Rentschler Biopharma announces strategic realignment of its global business operations
Rentschler Biopharma SE announces strategic realignment of global business operations, focusing on biologics and ceasing cell and gene therapy operations at Stevenage, UK site to drive innovation and sustainable growth

Innovation Strategic Realignment Biologics Rentschler Biopharma SE Global Business

Published on 01/30/2026 at 08:35, 5 hours 3 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 5 hours 38 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 11 hours 23 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 13 hours 38 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 14 hours 38 minutes ago

PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A

View all ACCESSWIRE

Published on 01/30/2026 at 12:00, 1 hour 38 minutes ago

HSBC UK and Sage simplify tax reporting for small businesses ahead of Making Tax Digital
Published on 01/30/2026 at 11:54, 1 hour 44 minutes ago

EQS-Adhoc: YOC AG: PRELIMINARY FIGURES FOR THE 2025 FINANCIAL YEAR
Published on 01/30/2026 at 10:30, 3 hours 8 minutes ago

ASTA ENERGY SOLUTIONS AG SUCCESSFULLY COMPLETES IPO
Published on 01/30/2026 at 10:00, 3 hours 38 minutes ago

Appointment of Managing Director of Tradegate BSX
Published on 01/30/2026 at 09:00, 4 hours 38 minutes ago

Original-Research: 123fahrschule SE (von NuWays AG): BUY

View all EQS

Published on 01/30/2026 at 08:00, 5 hours 38 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 19 hours 38 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 19 hours 53 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 19 hours 53 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 19 hours 58 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News